Key stats
About Harvest CSI Hong Kong Connect Innovative Drug Index ETF Units
Home page
Inception date
Jul 30, 2025
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
Harvest Fund Management Co., Ltd.
ISIN
CNE1000072C5
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
520970 assets under management is 1.02 B CNY. It's risen 134.88% over the last month.
520970 fund flows account for 122.65 M CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 520970 doesn't pay dividends to its holders.
520970 shares are issued by Harvest Fund Management Co., Ltd. under the brand Harvest. The ETF was launched on Jul 30, 2025, and its management style is Passive.
520970 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
520970 follows the CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
520970 trades at a premium (1.02%) meaning the ETF is trading at a higher price than the calculated NAV.